ORMP
Oramed Pharmaceuticals (ORMP)
$
38About Oramed Pharmaceuticals (ORMP)
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Details
Daily high
$2.38
Daily low
$2.34
Price at open
$2.38
52 Week High
$3.67
52 Week Low
$1.67
Market cap
97.0M
Dividend yield
0.00%
Volume
81,257
Avg. volume
83,875
P/E ratio
4.67
Oramed Pharmaceuticals News
Details
Daily high
$2.38
Daily low
$2.34
Price at open
$2.38
52 Week High
$3.67
52 Week Low
$1.67
Market cap
97.0M
Dividend yield
0.00%
Volume
81,257
Avg. volume
83,875
P/E ratio
4.67